A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...
Investors seeking stocks with explosive growth potential should consider the biotech industry. Drugmakers can experience ...
The problem, Zaaijer explained, is that algorithms used in precision medicine models overwhelming are built on DNA with ...
Sportschosun on MSN
Rare genetic disease Lever's optic nerve atrophy succeeded in gene correction treatment for the firs...
A research team led by Professor Lee Hyun-ji (co-first authors Kim Sang-hoon, Kim Ji-eun, Joo Sung-jin, PhD student at Korea University Medical School, and co-corresponding author Lee Hyun-ji) ...
India's GenAI infrastructure is being built, but can a public-private partnership outpace the trillion-dollar budgets of US ...
Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...
The Healthy @Reader's Digest on MSN
Breaking study: An experimental new drug could cut cholesterol for life
Cholesterol meds—taking by millions of Americans every day—often come with a lifelong prescription, adding out-of-pocket ...
Investor focus remains on Caribou Biosciences as the company continues to report compelling results from its core clinical programs for allogeneic CAR-T cell ...
In this edition of our Semi-Monthly Emeryville Newswire, we share 6 stories relevant to Emeryville that you may have missed, ...
The first 100 bases of many genes show excess mutations, revealing a major genomic weak spot that shapes disease risk and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback